- According to estimates from 9 analysts, NeoGenomics, Inc. stock's average price target has risen from $16.78 to $19.72, with forecasts ranging from $16 to $35 per share
- Based on the Jul. 28 closing price, the updated target implies approximately 47% potential upside
- Consensus rating remains at “Buy” across 12 covering analysts, with 8 Buys, 4 Holds and 0 Sells
Explore more price target data and ratings for NeoGenomics, Inc. on the , and track all previous and future analyst recommendations for NeoGenomics, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.